Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: RE37516

« Back to Dashboard

Summary for Patent: RE37516

Title: Acetamide derivative having defined particle size
Abstract:Pharmaceutical compositions comprising modafinil in the form of particles of defined size. The particle size of modafinil can have a significant effect on the potency and safety profile of the drug.
Inventor(s): Grebow; Peter E. (Penllyn, PA), Corvari; Vincent (Nahua, NH), Stong; David (Coatesville, PA)
Assignee: Cephalon, Inc. (West Chester, PA)
Application Number:09/285,166
Patent Claim Types:
see list of patent claims
Composition; Use; Dosage form;

No matches for this query

International Patent Family for Patent: RE37516

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria188607► Subscribe
Austria199216► Subscribe
Austria400260► Subscribe
Australia3509099► Subscribe
Australia3951495► Subscribe
Australia703087► Subscribe
Australia729586► Subscribe
Bulgaria101389► Subscribe
Bulgaria62952► Subscribe
Brazil9509257► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: